Description
Mutations in BRCA1 and BRCA2 can increase the risk of developing cancer. Mutations in these two genes are responsible for 5 to 10 % of all breast cancers in women. detection of deletions or duplications in the BRCA2 gene in genomic 2 DNA isolated from human peripheral whole blood specimens.
Test code(s)
BMG-621
TAT
5-7 business days
Accepted Sample requirements
EDTA Blood